1Fedarko NS, Jain A, Karadag A, et al. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res, 2001, 7(12):4060
2Zaia J, Boynton R, Heinegard D, et al. Posttranslational modifications to human bone sialoprotein determined by mass spectrometry. Biochemistry,2001, 40,12983
3Shaarawy M, HasanM. Serum bone sialoprotein:a marker of bone resorption in postmenopausal osteoporosis. Scand J Clin Lab Invest, 2001, 61(7) :513
4Fassbender WJ, Ruf T, Kaiser HE, et al. Serum levels of immunoreactive bone sialoprotein in osteoporosis: positive relations to established biochemical parameters of bone turnover. In Vivo, 2000, 14(5):619
5Sharp JA, Sung V, Slavin J, et al. Tumor cells are the source of esteopontin and bone sialoprotein expression in human breast cancer. Lab Invest, 1999, 79(7):869
6George L, Bames, Amjad Javed, et al. Osteoblast- related transcription factors runx2(Cbfal/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res, 2003,63(10) :2631
7Sung V, Stubbs JT, Fisher L, et al. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v) beta3 and alpha(v) beta5 integrins. J Cell Physiol,1998, 176(3) :482
8Zhang JH, Tang J, Wang J, et al. Over- expression of bone sialoprotein gene enhances bone metastasis of human breast cancer cells in a mouse model. IntJ Oncol, 2003, 23(4):1043
9Diel IJ, Solomayer EF, Seibel MJ, et al. Serum bone sialoprotein in patients with primary breast cancer is a prognoetic marker for subsequent bone metastasis. Clin Cancer Res, 1999,5(12) :3914
10Seibel MJ, Woitge HW, Pecherstorfer M, et al. Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease. J Clin Endocrinol Metab, 1996, 81(9):3289
2WUTTKE M, MULLER S, NITSCHE D P, et al. Structural characterization of human recombinant and bone - derived bone sialotrotein[ J]. J Biol Chem, 2001, 276(39) : 36 839 -36 848.
3KAKONEN S M, MUNDY G R. Mechanisms of osteolytic bone metastases in breast carcinoma[ J ]. Cancer, 2003 (3 Suppl) : 834 - 839.
4ZHANG J H, TANG J, WANG J. Over - expression of bone sialoprotein enhance bone metastasis of human breast cancer cells in a mouse model[J1. Int J Oncol, 2003, 23:1 043- 1 044.
5PAPOTTI M, KALEBIC T, VOLANTE M, et al. Thea Kalebie Bone sialoprotein is predictive of bone metastases in resectable non - small - cell Lung cancer: a retrospective case - control study [J]. J Clin Oncol, 2006, 24(30) : 4 818 -4 824.
6SHAARAWY M, HASAN M. Serum bone sialoprotein: a marker of bone resorption in postmenopausal osteoporosis [ J ]. Scand J Clin Lab Invest, 2001 ( 61 ) : 513 - 522.
7HAMMETr STABLER C A. The use of biochemical markers in osteoporosis[J]. Clin Lab Med, 2004, 24(1) : 175 -197.
8JAIN A, KARADAG A. Three SIBLINGS(small integrin- binding ligand, N - linked glyeoproteins) enhance factors H' s eofaetor activity enabling MCP - like cellular evasion of complement - mediated attack[J]. J Biol Chem, 2002, 277 (16): 13 700 - 13 708.
